Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-21-120896
Date:2021-09-27
Issuer: COHERUS BIOSCIENCES, INC. (CHRS)
Original Submission Date:

Reporting Person:

HEALY JAMES
C/O SOFINNOVA INVESTMENTS, INC.,
3000 SAND HILL ROAD, BLDG. 4, SUITE 250 MENLO PARK, CA 94025

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $0.0001 PAR VALUE 2021-09-27 S 100,150 d $18.06 334,405 indirect
COMMON STOCK, $0.0001 PAR VALUE 2021-09-28 S 48,329 d $17.17 286,076 indirect
COMMON STOCK, $0.0001 PAR VALUE 2021-09-29 S 286,076 d $16.12 0 indirect
COMMON STOCK, $0.0001 PAR VALUE 2021-09-27 0 $0.00 70,086 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $18.00 to $18.17, inclusive. the reporting person undertakes to provide to coherus biosciences, inc., any security holder of coherus biosciences, inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this form 4.
f2 the shares are held by sofinnova management vii, llc. the reporting person is the managing member of sofinnova management vii, llc. the reporting person disclaims beneficial ownership of the reported securities, except to the extent of his proportionate pecuniary interest in sofinnova management vii, llc.
f3 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $17.00 to $17.43, inclusive. the reporting person undertakes to provide to coherus biosciences, inc., any security holder of coherus biosciences, inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this form 4.
f4 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $16.05 to $16.905, inclusive. the reporting person undertakes to provide to coherus biosciences, inc., any security holder of coherus biosciences, inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this form 4.
WhaleWisdom Logo

Elevate your investments